Lv1
80 积分 2024-12-12 加入
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
15天前
已完结
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
15天前
已完结
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study
30天前
已完结
ABCL-192 ACRUE: A Phase 2, Open-Label Study of Acalabrutinib in Combination With Rituximab in Elderly and/or Frail Patients With Treatment-Naive Diffuse Large B-Cell Lymphoma
1个月前
已完结
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
5个月前
已完结
Application Value of Chemiluminescence Immunoassay in Thyroid Function Biochemical Testing
11个月前
已完结
皖公网安备34019202002308
